RSS Feeds
Search

PR Newswire

News of the day

CEM Wins Peptide Patent Dispute with Biotage

9th May 2013 MATTHEWS, North Carolina, May 9, 2013 /PRNewswire/ -- CEM Corporation, a leading global provider of microwave laboratory instrumentation is pleased to announce that its European Patent No. 1 491 552 covering microwave assisted solid phase peptide synthesis has been upheld in an oral proceeding at the European Patent Office. The opposition proceeding had been initiated by Biotage in an attempt to revoke the patent. The patent broadly covers the overall process of microwave peptide synthesis... more

EPO appeal board decides in favor of the Wengel LNA patent

18th April 2013 HOERSHOLM, Denmark and SAN DIEGO, April 18, 2013 /PRNewswire/ -- Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that the EPO has issued Minutes of the Oral Proceedings specifying the Board of Appeal's decision to maintain EP 1015469, the "Wengel" patent, with the claims to amino- and thio-LNA nucleotides and oligonucleotides. (Logo: http://photos.prnewswire.com/prnh/20100111/SPLOGO) more

Simbionix Revolutionary Patient Specific Simulation PROcedure Rehearsal Studio(TM) Receives First of its Kind US Patent

5th April 2013 CLEVELAND, April 5, 2013 /PRNewswire/ -- more
RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
 

Category

To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Most viewed

CPA Acquires Renowned German Patent Research Specialist, SVPG
Occlutech Clarifies Statement Regarding Favourable Opinion Obtained From AIPPI With Regard to Patents Held by AGA Medical
Enigma Diagnostics Announces a Signed Term Sheet for Patent Licenses with Roche Molecular Systems, Inc.
Neptune Technologies Patent Granted for Novel Phospholipids in Multiple Diseases and Pharmaceutical Applications
Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals
Most viewed Patent Law RSS feed

Browse by category

More recent news

USPTO issues Inter Partes Reexamination Certificate of key LNA patent
5th April 2013 HOERSHOLM, Denmark and SAN DIEGO, April 5, 2013 /PRNewswire/ -- Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies,...

Japan Biosimilars - ¥200b Worth of Biologic Products Going Off Patent by 2015
12th February 2013 MUMBAI, India, February 12, 2013 /PRNewswire/ --

USPTO Grants Santaris' Request for Inter-Partes Reexamination of Patent licensed to Regulus
7th January 2013

EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals
28th December 2012 MIAMI, December 28, 2012 /PRNewswire/ --

ConvaTec Prevails In Patent Case Brought By Smith & Nephew
19th December 2012

Janssen Announces Intent Not to Enforce Patents for Darunavir in Resource-Limited Settings
29th November 2012

Another Patent Granted to COPAN in the US for its Flocked Swabs Invention
12th November 2012

Harvest Technologies Corporation Files Patent Infringement Complaint against ThermoGenesis Corporation
24th October 2012

Court Focuses Patent Suit on Santaris's Safe Harbor Defense
24th September 2012

Lupin Receives FDA Approval for Generic Lexapro® Tablets
13th September 2012 MUMBAI, India and BALTIMORE, Maryland, September 13, 2012 /PRNewswire/ --

/C O R R E C T I O N -- Jazz Pharmaceuticals/
13th September 2012

Jazz Pharmaceuticals Announces Issuance of New Formulation Patent for Xyrem®
11th September 2012

Puritan Diagnostics, a division of Puritan Medical Products, Announces the Award of U.S. and Canadian Patents for HydraFlock® Swab
4th September 2012

Lupin Receives FDA Approval for Generic LYRICA(R)
5th July 2012 MUMBAI and BALTIMORE, July 5, 2012 /PRNewswire/ --

Genomic Vision Extends its Patent Portfolio With the Genomic Morse Code
3rd July 2012 PARIS, July 3, 2012 /PRNewswire/ --

ThromboGenics to Benefit From Positive Ruling Regarding Patent Income Deduction
22nd June 2012 LEUVEN, Belgium, June 22, 2012 /PRNewswire/ --

ThromboGenics and BioInvent to Regain Full Rights to TB-403
5th June 2012 LUND, Sweden and LEUVEN, Belgium, June 5, 2012 /PRNewswire/ --

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us